{
    "2020-01-10": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Regeneron's Phase II Candidate Promising in Primary Analysis",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Phase II",
                        "Candidate",
                        "Promising",
                        "Primary Analysis"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "3 Biotech Stocks to Bank on for Buyouts in 2020",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stocks",
                        "Bank",
                        "Buyouts",
                        "2020"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Highlights",
                        "Novartis",
                        "McDonald's",
                        "Bristol-Myers Squibb",
                        "CME",
                        "UBS"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods",
                        "financial services"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}